• Home
  • Pharmaceuticals and Healthcare
Cell and Advanced Therapies Supply Chain Management Market - Global Outlook and Forecast 2021-2027

Cell and Advanced Therapies Supply Chain Management Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687574 | No. of Pages: 102 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Cell and Advanced Therapies Supply Chain Management in Global, including the following market information:
Global Cell and Advanced Therapies Supply Chain Management Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Cell and Advanced Therapies Supply Chain Management market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell and Advanced Therapies Supply Chain Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Advanced Therapies Supply Chain Management Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Cell and Advanced Therapies Supply Chain Management Market Segment Percentages, By Type, 2020 (%)
Cloud
On-premises

China Cell and Advanced Therapies Supply Chain Management Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Cell and Advanced Therapies Supply Chain Management Market Segment Percentages, By Application, 2020 (%)
Biobank
Cell Therapy Lab
Hospital
Research Institute
Commercial Organization

Global Cell and Advanced Therapies Supply Chain Management Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Cell and Advanced Therapies Supply Chain Management Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Cell and Advanced Therapies Supply Chain Management Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Cell and Advanced Therapies Supply Chain Management Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Be The Match BioTherapies
Brooks Life Sciences
Clarkston Consulting
Cryoport
Haemonetics
Hypertrust Patient Data Care
Lykan Bioscience
MAK-SYSTEM
MasterControl
SAP
SAVSU Technologies
sedApta Group
Stafa Cellular Therapy
Title21 Health Solutions
TraceLink
TrakCel
Vineti
1 Introduction to Research & Analysis Reports
    1.1 Cell and Advanced Therapies Supply Chain Management Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cell and Advanced Therapies Supply Chain Management Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cell and Advanced Therapies Supply Chain Management Overall Market Size
    2.1 Global Cell and Advanced Therapies Supply Chain Management Market Size: 2021 VS 2027
    2.2 Global Cell and Advanced Therapies Supply Chain Management Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cell and Advanced Therapies Supply Chain Management Players in Global Market
    3.2 Top Global Cell and Advanced Therapies Supply Chain Management Companies Ranked by Revenue
    3.3 Global Cell and Advanced Therapies Supply Chain Management Revenue by Companies
    3.4 Top 3 and Top 5 Cell and Advanced Therapies Supply Chain Management Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Cell and Advanced Therapies Supply Chain Management Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cell and Advanced Therapies Supply Chain Management Players in Global Market
        3.6.1 List of Global Tier 1 Cell and Advanced Therapies Supply Chain Management Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cell and Advanced Therapies Supply Chain Management Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Cell and Advanced Therapies Supply Chain Management Market Size Markets, 2021 & 2027
        4.1.2 Cloud
        4.1.3 On-premises
    4.2 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue & Forecasts
        4.2.1 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2021
        4.2.2 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2022-2027
        4.2.3 By Type - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cell and Advanced Therapies Supply Chain Management Market Size, 2021 & 2027
        5.1.2 Biobank
        5.1.3 Cell Therapy Lab
        5.1.4 Hospital
        5.1.5 Research Institute
        5.1.6 Commercial Organization
    5.2 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue & Forecasts
        5.2.1 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2021
        5.2.2 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2022-2027
        5.2.3 By Application - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Cell and Advanced Therapies Supply Chain Management Market Size, 2021 & 2027
    6.2 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue & Forecasts
        6.2.1 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2021
        6.2.2 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue, 2022-2027
        6.2.3 By Region - Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
        6.3.2 US Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.3.3 Canada Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.3.4 Mexico Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
        6.4.2 Germany Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.4.3 France Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.4.4 U.K. Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.4.5 Italy Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.4.6 Russia Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.4.7 Nordic Countries Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.4.8 Benelux Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
        6.5.2 China Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.5.3 Japan Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.5.4 South Korea Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.5.5 Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.5.6 India Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
        6.6.2 Brazil Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.6.3 Argentina Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cell and Advanced Therapies Supply Chain Management Revenue, 2016-2027
        6.7.2 Turkey Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.7.3 Israel Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.7.4 Saudi Arabia Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
        6.7.5 UAE Cell and Advanced Therapies Supply Chain Management Market Size, 2016-2027
7 Players Profiles
    7.1 Be The Match BioTherapies
        7.1.1 Be The Match BioTherapies Corporate Summary
        7.1.2 Be The Match BioTherapies Business Overview
        7.1.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.1.4 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.1.5 Be The Match BioTherapies Key News
    7.2 Brooks Life Sciences
        7.2.1 Brooks Life Sciences Corporate Summary
        7.2.2 Brooks Life Sciences Business Overview
        7.2.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.2.4 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.2.5 Brooks Life Sciences Key News
    7.3 Clarkston Consulting
        7.3.1 Clarkston Consulting Corporate Summary
        7.3.2 Clarkston Consulting Business Overview
        7.3.3 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.3.4 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.3.5 Clarkston Consulting Key News
    7.4 Cryoport
        7.4.1 Cryoport Corporate Summary
        7.4.2 Cryoport Business Overview
        7.4.3 Cryoport Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.4.4 Cryoport Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.4.5 Cryoport Key News
    7.5 Haemonetics
        7.5.1 Haemonetics Corporate Summary
        7.5.2 Haemonetics Business Overview
        7.5.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.5.4 Haemonetics Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.5.5 Haemonetics Key News
    7.6 Hypertrust Patient Data Care
        7.6.1 Hypertrust Patient Data Care Corporate Summary
        7.6.2 Hypertrust Patient Data Care Business Overview
        7.6.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.6.4 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.6.5 Hypertrust Patient Data Care Key News
    7.7 Lykan Bioscience
        7.7.1 Lykan Bioscience Corporate Summary
        7.7.2 Lykan Bioscience Business Overview
        7.7.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.4.4 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.7.5 Lykan Bioscience Key News
    7.8 MAK-SYSTEM
        7.8.1 MAK-SYSTEM Corporate Summary
        7.8.2 MAK-SYSTEM Business Overview
        7.8.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.8.4 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.8.5 MAK-SYSTEM Key News
    7.9 MasterControl
        7.9.1 MasterControl Corporate Summary
        7.9.2 MasterControl Business Overview
        7.9.3 MasterControl Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.9.4 MasterControl Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.9.5 MasterControl Key News
    7.10 SAP
        7.10.1 SAP Corporate Summary
        7.10.2 SAP Business Overview
        7.10.3 SAP Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.10.4 SAP Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.10.5 SAP Key News
    7.11 SAVSU Technologies
        7.11.1 SAVSU Technologies Corporate Summary
        7.11.2 SAVSU Technologies Business Overview
        7.11.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.11.4 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.11.5 SAVSU Technologies Key News
    7.12 sedApta Group
        7.12.1 sedApta Group Corporate Summary
        7.12.2 sedApta Group Business Overview
        7.12.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.12.4 sedApta Group Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.12.5 sedApta Group Key News
    7.13 Stafa Cellular Therapy
        7.13.1 Stafa Cellular Therapy Corporate Summary
        7.13.2 Stafa Cellular Therapy Business Overview
        7.13.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.13.4 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.13.5 Stafa Cellular Therapy Key News
    7.14 Title21 Health Solutions
        7.14.1 Title21 Health Solutions Corporate Summary
        7.14.2 Title21 Health Solutions Business Overview
        7.14.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.14.4 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.14.5 Title21 Health Solutions Key News
    7.15 TraceLink
        7.15.1 TraceLink Corporate Summary
        7.15.2 TraceLink Business Overview
        7.15.3 TraceLink Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.15.4 TraceLink Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.15.5 TraceLink Key News
    7.16 TrakCel
        7.16.1 TrakCel Corporate Summary
        7.16.2 TrakCel Business Overview
        7.16.3 TrakCel Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.16.4 TrakCel Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.16.5 TrakCel Key News
    7.17 Vineti
        7.17.1 Vineti Corporate Summary
        7.17.2 Vineti Business Overview
        7.17.3 Vineti Cell and Advanced Therapies Supply Chain Management Major Product Offerings
        7.17.4 Vineti Cell and Advanced Therapies Supply Chain Management Revenue in Global (2016-2021)
        7.17.5 Vineti Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com